β受体阻滞剂对心肌梗死后室性心律失常和交感神经重构的影响  

Effect of β-blockers on Ventricular Arrhythmias and Sympathetic Remodeling after Myocardial Infarction

作　　者：印婷婷[1] 汤宝鹏[1] 

机构地区：[1]新疆医科大学第一附属医院心脏起搏电生理科,新疆乌鲁木齐830054

出　　处：《心血管病学进展》2015年第1期58-62,共5页Advances in Cardiovascular Diseases

基　　金：新疆维吾尔自治区心血管病研究实验室开放课题项目(XJDX0903-2013-03)

摘　　要：室性心律失常是引起心肌梗死患者早期死亡的主要原因,而β受体阻滞剂对心肌梗死后患者的保护作用已经得到广泛的认可,早期治疗和预防心肌梗死室性心律失常成为降低心肌梗死患者病死率的重要措施。Ventricular arrhythmia is the main cause of an early death in patients with myocardial infarction. The protective effect of β-blockers in patients after myocardial infarction has been widely recognized. The early treatment and prevention of ventricular arrhythmia after myocardial infarction has become an important measure to reduce the mortality in patients with myocardial infarction.

关 键 词：Β受体阻滞剂 心肌梗死 室性心律失常 交感神经重构 

分 类 号：R542.2[医药卫生—心血管疾病] R541.7[医药卫生—内科学]